Important Roles and Potential Uses of Natural and Synthetic Antimicrobial Peptides (AMPs) in Oral Diseases: Cavity, Periodontal Disease, and Thrush
Source abstract
Abstract
Numerous epithelial cells and sometimes leukocytes release AMPs as their first line of defense. AMPs encompass cationic histatins, defensins, and cathelicidin to encounter oral pathogens with minimal resistance. However, their concentrations are significantly below the effective levels and AMPs are unstable under physiological conditions due to proteolysis, acid hydrolysis, and salt effects. In parallel to a search for more effective AMPs from natural sources, considerable efforts have focused on synthetic stable and low-cytotoxicy AMPs with significant activities against microorganisms. Using natural AMP templates, various attempts have been used to synthesize sAMPs with different charges, hydrophobicity, chain length, amino acid sequence, and amphipathicity. Thus far, sAMPs have been designed to target Streptococcus mutans and other common oral pathogens. Apart from sAMPs with antifungal activities against Candida albicans, future endeavors should focus on sAMPs with capabilities to promote remineralization and antibacterial adhesion. Delivery systems using nanomaterials and biomolecules are promising to stabilize, reduce cytotoxicity, and improve the antimicrobial activities of AMPs against oral pathogens. Nanostructured AMPs will soon become a viable alternative to antibiotics due to their antimicrobial mechanisms, broad-spectrum antimicrobial activity, low drug residue, and ease of synthesis and modification.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Antimicrobial Peptides and Activities · Biochemical and Structural Characterization · Oral microbiology and periodontitis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University of Buffalo, Buffalo, NY 14215, USA
Department of Chemistry, College of Science, King Faisal University, P.O. Box 380, Al-Ahsa 31982, Saudi Arabia
School of Chemistry and Analytical & Biological Chemistry Research Facility (ABCRF), University College Cork, College Road, T12 YN60 Cork, Ireland
References (100+)
Show source-provided references
1. A natural history of dental caries lesions: A 4-year observational study10.1177/0022034512455030 ↗
2. Oral microbiome: Unveiling the fundamentals10.4103/jomfp.JOMFP_304_18 ↗
3. The oral microbiome in dental caries10.33073/pjm-2014-018 ↗
4. Can the ecology of the dental biofilm be beneficially altered?10.1177/0895937409335641 ↗
5. Isolation of dental caries bacteria from dental plaque and effect of toothpastes on acidogenic bacteria10.4236/ojmm.2012.23009 ↗
6. The effects of lesion baseline characteristics and different Sr: Ca ratios in plaque fluid-like solutions on caries lesion de- and remineralization10.1016/j.archoralbio.2012.08.012 ↗
7. Anti-microbial efficacy of green tea and chlorhexidine mouth rinses against Streptococcus mutans, Lactobacilli spp. and Candida albicans in children with severe early childhood caries: A randomized clinical study10.4103/0970-4388.175518 ↗
8. A model of efficiency: Stress tolerance by Streptococcus mutans10.1099/mic.0.2008/023770-0 ↗
9. Demonstration of Streptococcus mutans with a cell wall polysaccharide specific to a new serotype, k, in the human oral cavity10.1128/JCM.42.1.198-202.2004 ↗
10. Serotype classification of Streptococcus mutans and its detection outside the oral cavity10.2217/fmb.09.64 ↗
11. Arsenic trioxide associated toothache10.1177/1078155209338727 ↗
12. Bacteriocins-a viable alternative to antibiotics?10.1038/nrmicro2937 ↗
13. Inhibition of experimental dental caries in the rat by fluoride and iodoacetic acid10.3181/00379727-39-10215 ↗
14. On the bacterial factor in the etiology of dental caries
15. Present and future measures for dental caries control10.14219/jada.archive.1969.0037 ↗
16. Further studies on extracellular glucans synthesized by glucosyltransferases of oral streptococci10.1159/000260207 ↗
17. Solving the etiology of dental caries10.1016/j.tim.2014.10.010 ↗
18. Optimization of adhesive pastes for dental caries prevention10.1208/s12249-017-0750-0 ↗
19. Role of microbial biofilms in the maintenance of oral health and in the development of dental caries and periodontal diseases. Consensus report of group 1 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal disease10.1111/jcpe.12682 ↗
20. Toward dental caries: Exploring nanoparticle-based platforms and calcium phosphate compounds for dental restorative materials10.1016/j.bioactmat.2018.12.002 ↗
21. The numerous microbial species in oral biofilms: How could antibacterial therapy be effective?10.1177/0022034512450028 ↗
22. Reducing dental plaque formation and caries development. A review of current methods and implications for novel pharmaceuticals
23. Controlling the oral biofilm with antimicrobials10.1016/S0300-5712(10)70005-1 ↗
24. Chlorhexidine and hypersensitivity reactions in dentistry10.1038/sj.bdj.2012.1086 ↗
25. Wilkins, E.M., Wyche, C.J., Boyd, L.D., and Mallonee, L.F. (2021). Clinical Practice of the Dental Hygienist, Jones Bartlett Learning. [13th ed.].
26. Anionic antimicrobial peptides from eukaryotic organisms10.2174/138920309789630589 ↗
27. An in vitro synergetic evaluation of the use of nisin and sodium fluoride or chlorhexidine against Streptococcus mutans10.1016/j.peptides.2011.09.002 ↗
28. Glycation of the muscle specific enolase by reactive carbonyls: Effect of temperature and the protection role of carnosine; pirydoxamine and phosphatidylserine10.1007/s10930-011-9307-3 ↗
29. Liao, Y., Chen, J., Brandt, B.W., Zhu, Y., Li, J., van Loveren, C., and Deng, D.M. (2015). Identification and functional analysis of genome mutations in a fluoride-resistant Streptococcus mutans strain. PloS ONE, 10.10.1371/journal.pone.0122630 ↗
30. Chlorhexidine: The gold standard antiplaque agent
31. Resistance toward chlorhexidine in oral bacteria-is there cause for concern10.3389/fmicb.2019.00587 ↗
32. Proteomic analyses of chlorhexidine tolerance mechanisms in Delftia acidovorans biofilms10.1128/mSphere.00017-15 ↗
33. Chlorhexidine-pharmaco-biological activity and application
34. Antimicrobial activity of alexidine; chlorhexidine and cetrimide against Streptococcus mutans biofilm10.1186/s12941-014-0041-5 ↗
35. The effect of quaternary ammonium compounds on stomach emptying10.1248/yakushi1947.97.7_801 ↗
36. Effect of charge density of bonding agent containing a new quaternary ammonium methacrylate on antibacterial and bonding properties10.1016/j.dental.2014.01.002 ↗
37. Effects of quaternary ammonium chain length on the antibacterial and remineralizing effects of a calcium phosphate nanocomposite10.1038/ijos.2015.33 ↗
38. Triclosan: A widely used biocide and its link to antibiotics10.1111/j.1574-6968.2001.tb10772.x ↗
39. Triclosan inhibition of fatty acid synthesis and its effect on growth of Escherichia coli and Pseudomonas aeruginosa10.1093/jac/dki123 ↗
40. The widely used antimicrobial triclosan induces high levels of antibiotic tolerance in vitro and reduces antibiotic efficacy up to 100-fold in vivo10.1128/AAC.02312-18 ↗
41. (2022, October 01). Available online: https://beyondpesticides.org/dailynewsblog/2012/08/johnson-and-johnson-to-phase-out-triclosan-regulators-remain-unresponsive/.
42. Helicobacter pylori and oral pathology: Relationship with the gastric infection10.3748/wjg.v20.i29.9922 ↗
43. Viral infections of oral cavity10.4103/jfmpc.jfmpc_807_19 ↗
44. Peptides to combat viral infectious diseases10.1016/j.peptides.2020.170402 ↗
45. Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: Issues associated with study design10.1007/s10096-012-1795-3 ↗
46. Antibiotic overuse and resistance in dermatology10.1111/j.1529-8019.2012.01520.x ↗
47. Dental plaque as a microbial biofilm10.1159/000077756 ↗
48. Antibiotic therapy in dentistry
49. Beta-lactam antibiotics induce a lethal malfunctioning of the bacterial cell wall synthesis machinery10.1016/j.cell.2014.11.017 ↗
50. Antibacterial effects of different concentrations of Althaea officinalis root extract versus 0.2% chlorhexidine and penicillin on Streptococcus mutans and Lactobacillus (in vitro)10.4103/jispcd.JISPCD_150_17 ↗
51. Oral microbial colonization in children with sickle cell anaemia under long-term prophylaxis with penicillin10.1016/j.archoralbio.2014.05.014 ↗
52. The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A10.1128/AAC.02333-15 ↗
53. Sensitivity and selectivity on aptamer-based assay: The determination of tetracycline residue in bovine milk10.1100/2012/159456 ↗
54. Patil, S.D., Sharma, R., Srivastava, S., Navani, N.K., and Pathania, R. (2013). Downregulation of yidC in Escherichia coli by antisense RNA expression results in sensitization to antibacterial essential oils eugenol and carvacrol. PloS ONE, 8.10.1371/journal.pone.0057370 ↗
55. Tetracycline nephrotoxicity and nonoliguric acute renal failure10.1001/archinte.1966.00290140027006 ↗
56. Tetracycline: A cure all?10.1016/j.bjoms.2014.01.020 ↗
57. Tetracycline-incorporated polymer nanofibers as a potential dental implant surface modifier10.1002/jbm.b.33743 ↗
58. Mechanism of action of metronidazole on Bacteroides fragilis10.1093/infdis/148.6.1083 ↗
59. (2022, October 01). Available online: https://www.mayoclinic.org/drugs-supplements/metronidazole-oral-route/side-effects/drg-20064745.
60. Macrolides and changes in the oral flora10.1016/S0924-8579(98)00100-9 ↗
61. The macrolides: Erythromycin; clarithromycin; and azithromycin10.4065/74.6.613 ↗
62. Comparative in-vitro activity of azithromycin; macrolides (erythromycin; clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms10.1093/jac/30.1.27 ↗
63. The bacterial ribosome as a target for antibiotics10.1038/nrmicro1265 ↗
64. Bacterial protein synthesis as a target for antibiotic inhibition10.1101/cshperspect.a025361 ↗
65. (2022, October 01). Available online: https://www.healthline.com/health/clindamycin-for-tooth-infection.
66. Kumar, P., Kizhakkedathu, J.N., and Straus, S.K. (2018). Antimicrobial peptides: Diversity; mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules, 8.10.3390/biom8010004 ↗
67. Antimicrobial peptides: Classification; design; application and research progress in multiple fields10.3389/fmicb.2020.582779 ↗
68. Antibiofilm peptides against oral biofilms10.1080/20002297.2017.1327308 ↗
69. Enlarged scale chemical synthesis and range of activity of drosocin; an O-glycosylated antibacterial peptide of Drosophila10.1111/j.1432-1033.1996.0064q.x ↗
70. Alternative mechanisms of action of cationic antimicrobial peptides on bacteria10.1586/14787210.5.6.951 ↗
71. The potential of modified and multimeric antimicrobial peptide materials as superbug killers10.3389/fchem.2021.795433 ↗
72. Antimicrobial peptides and bacteriocins: Alternatives to traditional antibiotics10.1017/S1466252308001497 ↗
73. The antimicrobial peptide, LL-37, inhibits in vitro osteoclastogenesis10.1177/0022034512460402 ↗
74. Structure; function; and membrane integration of defensins10.1016/0959-440X(95)80038-7 ↗
75. Antimicrobial peptides in defence of the oral and respiratory tracts10.1016/S0161-5890(03)00162-7 ↗
76. An evolutionary perspective of mammal salivary peptide families: Cystatins; histatins; statherin and PRPs10.1016/j.archoralbio.2012.12.011 ↗
77. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation; characterization; primary structure; and fungistatic effects on Candida albicans10.1016/S0021-9258(18)68522-9 ↗
78. Histatins enhance wound closure with oral and non-oral cells10.1177/0022034509342951 ↗
79. The influence of histatin-5 fragments on the mineralization of hydroxyapatite10.1016/0003-9969(93)90113-Z ↗
80. A plausible role of salivary copper in antimicrobial activity of histatin-5-metal binding and oxidative activity of its copper complex10.1016/j.bmcl.2009.09.119 ↗
81. Human antimicrobial peptides and proteins10.3390/ph7050545 ↗
82. Yang, M., Zhang, C., Zhang, M.Z., and Zhang, S. (2018). Beta-defensin derived cationic antimicrobial peptides with potent killing activity against gram negative and gram positive bacteria. BMC Microbiol., 18.10.1186/s12866-018-1190-z ↗
83. Defensins: Antimicrobial peptides of innate immunity10.1038/nri1180 ↗
84. Primary structures of three human neutrophil defensins10.1172/JCI112121 ↗
85. Defensins, natural peptide antibiotics of human neutrophils10.1172/JCI112120 ↗
86. Purification and characterization of human neutrophil peptide 4; A novel member of the defensin family10.1016/S0021-9258(18)60449-1 ↗
87. Defensins in the oral cavity: Distribution and biological role10.1111/j.1600-0714.2009.00832.x ↗
88. Antimicrobial peptides in periodontal innate defense10.1159/000329673 ↗
89. Defensin antimicrobial peptides in the oral cavity10.1034/j.1600-0714.2001.300601.x ↗
90. Purification; primary structures; and antibacterial activities of β-defensins; a new family of antimicrobial peptides from bovine neutrophils10.1016/S0021-9258(18)53298-1 ↗
91. Comprehensive defensin assay for saliva10.1021/ac801609r ↗
92. Salivary antimicrobial peptide expression and dental caries experience in children10.1128/AAC.49.9.3883-3888.2005 ↗
93. Expression of the peptide antibiotic human b-defensin 1 in cultured gingival epithelial cells and gingival tissue10.1128/IAI.66.9.4222-4228.1998 ↗
94. Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study10.1078/0344-0338-00298 ↗
95. Diverse toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages10.1128/IAI.01226-13 ↗
96. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides; β-defensins and LL37; produced by human epithelial cells10.1093/jac/dki103 ↗
97. Human β-defensins 2 and demonstrate strain selective activity against oral microorganisms10.1128/JCM.42.3.1024-1029.2004 ↗
98. Treponema denticola suppresses expression of human β-defensin-2 in gingival epithelial cells through inhibition of TNFα production and TLR2 activation10.1007/s10059-010-0048-5 ↗
99. Interaction with phospholipid bilayers; ion channel formation; and antimicrobial activity of basic amphipathic α-helical model peptides of various chain lengths10.1016/S0021-9258(18)54912-7 ↗
100. Beta-defensins: What are they really doing in the oral cavity?10.1111/j.1601-0825.2011.01799.x ↗